Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
Abstract As of today, there is no antiviral for the treatment of the SARS-CoV-2 infection, and the development of a vaccine might take several months or even years. The structural superposition of the hepatitis C virus polymerase bound to sofosbuvir, a nucleoside analog antiviral approved for hepati...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/27f5e92cc72e48598ae0a79c08b15f67 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|